Paolo Ferrari
#140,207
Most Influential Person Now
Researcher
Paolo Ferrari's AcademicInfluence.com Rankings
Paolo Ferraricomputer-science Degrees
Computer Science
#6682
World Rank
#7042
Historical Rank
Computational Linguistics
#1204
World Rank
#1218
Historical Rank
Machine Learning
#2249
World Rank
#2277
Historical Rank
Artificial Intelligence
#2515
World Rank
#2556
Historical Rank
Download Badge
Computer Science
Paolo Ferrari's Degrees
- PhD Computer Science University of Milan
- Masters Computer Engineering Polytechnic University of Milan
- Bachelors Computer Engineering Polytechnic University of Milan
Similar Degrees You Can Earn
Why Is Paolo Ferrari Influential?
(Suggest an Edit or Addition)Paolo Ferrari's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology (2020) (957)
- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift (2021) (670)
- Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity (2021) (443)
- Comparison of continuous and intermittent renal replacement therapy for acute renal failure. (2005) (318)
- Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. (2001) (287)
- Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. (1996) (267)
- Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. (1991) (225)
- Insulin, insulin sensitivity and hypertension. (1990) (181)
- Broad betacoronavirus neutralization by a stem helix–specific human antibody (2021) (173)
- Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2. (1999) (163)
- Sodium pump α2 subunits control myogenic tone and blood pressure in mice (2005) (160)
- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift (2021) (157)
- Organ Hypertrophic Signaling within Caveolae Membrane Subdomains Triggered by Ouabain and Antagonized by PST 2238* (2004) (148)
- The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension. (2010) (145)
- Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin, Part 2: Clinical Studies (2010) (145)
- Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts. (2003) (145)
- In Vivo 11&bgr;-HSD-2 Activity: Variability, Salt-Sensitivity, and Effect of Licorice (2001) (138)
- A genetic defect resulting in mild low-renin hypertension. (1998) (135)
- Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade (2002) (134)
- Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. (2001) (133)
- Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease. (2011) (126)
- Adducin Polymorphism: Detection and Impact on Hypertension and Related Disorders (2005) (124)
- Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents (1993) (124)
- Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. (1997) (123)
- Evidence for an interaction between adducin and Na+-K+-ATPase: relation to genetic hypertension. (1999) (122)
- A RENAL ABNORMALITY AS A POSSIBLE CAUSE OF "ESSENTIAL" HYPERTENSION (1979) (122)
- Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients (2001) (115)
- Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure (2000) (110)
- Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism (2004) (110)
- Central Role of Sodium in Hypertension in Diabetic Subjects (1991) (109)
- Kidney paired donation: principles, protocols and programs. (2015) (108)
- The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity (2020) (103)
- Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. (1992) (102)
- Red blood cell abnormalities and spontaneous hypertension in the rat. A genetically determined link. (1985) (102)
- Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension. (2006) (101)
- PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain. (1998) (97)
- Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice. (2005) (97)
- Renal Na,K-ATPase in genetic hypertension. (1996) (95)
- The role of the 11β‐hydroxysteroid dehydrogenase type 2 in human hypertension (2000) (93)
- Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. (1990) (92)
- Antihypertensive agents, serum lipoproteins and glucose metabolism. (1991) (87)
- Familial aggregation of cation transport abnormalities and essential hypertension. (1981) (84)
- Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. (2005) (82)
- Role of the 11β-hydroxysteroid dehydrogenase type 2 in blood pressure regulation (2000) (82)
- Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. (2006) (80)
- Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2 (2021) (74)
- Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease. (2003) (74)
- PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. (1999) (71)
- Hypoxia causes down‐regulation of 11β‐hydroxysteroid dehydrogenase type 2 by induction of Egr‐1 (2003) (70)
- Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients1 (2002) (67)
- Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study (2004) (66)
- Paired kidney donations to expand the living donor pool. (2009) (64)
- Ouabainlike factor in Milan hypertensive rats. (1992) (63)
- Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure. (2007) (63)
- Point mutations abolish 11β-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess (1996) (63)
- The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess. (1995) (62)
- Serum Lipoproteins During Treatment with Antihypertensive Drugs (1993) (60)
- Immune changes in post-menopausal osteoporosis: the Immunos study (2010) (59)
- Pharmacological Profile of the Novel Inotropic Agent (E,Z)-3-((2-Aminoethoxy)imino)androstane-6,17-dione Hydrochloride (PST2744) (2002) (59)
- A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. (2003) (59)
- Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland (2020) (58)
- Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition (2013) (58)
- A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene. (1998) (56)
- Modulation of Sarcoplasmic Reticulum Function by Na+/K+ Pump Inhibitors with Different Toxicity: Digoxin and PST2744 [(E,Z)-3-((2-Aminoethoxy)imino)androstane-6,17-dione Hydrochloride] (2005) (56)
- Upregulation of Na+/Ca2+ exchanger and TRPC6 contributes to abnormal Ca2+ homeostasis in arterial smooth muscle cells from Milan hypertensive rats. (2010) (56)
- Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries (2009) (56)
- Renal dysfunction as a possible cause of essential hypertension in predisposed subjects. (1983) (56)
- ABO-Incompatible Matching Significantly Enhances Transplant Rates in Kidney Paired Donation (2013) (56)
- alpha-Adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorption. (2008) (55)
- Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. (2013) (53)
- Diverse Toxicity Associated with Cardiac Na+/K+ Pump Inhibition: Evaluation of Electrophysiological Mechanisms (2003) (53)
- Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism (2005) (52)
- Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy. (2013) (52)
- Abnormalities of insulin and lipid metabolism in Milan hypertensive rats. (1991) (51)
- Rat 11β-hydroxysteroid dehydrogenase type 2 enzyme is expressed at low levels in the placenta and is modulated by adrenal steroids in the kidney (1996) (50)
- Imprinted antibody responses against SARS-CoV-2 Omicron sublineages (2022) (50)
- Preoperative Endogenous Ouabain Predicts Acute Kidney Injury in Cardiac Surgery Patients* (2013) (49)
- Erythrocyte membrane and renal function in relation to hypertension in rats of the Milan hypertensive strain (1982) (49)
- 17β-(3-Furyl)-5β-androstane-3β,14β,17α-triol (PST 2238). A Very Potent Antihypertensive Agent with a Novel Mechanism of Action (1997) (49)
- Effect of donor-recipient age difference on graft function and survival in live-donor kidney transplantation. (2011) (49)
- Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria. (2002) (49)
- A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension. (2001) (49)
- Na+/K+/Cl(-)-cotransporter mediated Rb+ fluxes in membrane vesicles from kidneys of normotensive and hypertensive rats. (1990) (47)
- Kidney transplantation in rats: An appraisal of surgical techniques and outcome (2003) (46)
- Virtual Crossmatch Approach to Maximize Matching in Paired Kidney Donation (2011) (46)
- Effect of diuretics on the plasma lipid profile. (1992) (46)
- Altered expression of renal apical plasma membrane Na+ transporters in the early phase of genetic hypertension. (2005) (45)
- Swiss Hypertension and Risk Factor Program (SHARP): Cardiovascular risk factors management in patients with type 2 diabetes in Switzerland (2005) (45)
- Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis. (2003) (45)
- Erythrocyte adducin differential properties in the normotensive and hypertensive rats of the Milan strain. Characterization of spleen adducin m-RNA. (1989) (43)
- Dysregulation of atrial natriuretic factor in hypertension-prone man. (1990) (43)
- Upregulation of apical sodium-chloride cotransporter and basolateral chloride channels is responsible for the maintenance of salt-sensitive hypertension. (2008) (43)
- Oxoreductase and Dehydrogenase Activities of the Human and Rat 11β-Hydroxysteroid Dehydrogenase Type 2 Enzyme. (1997) (42)
- Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess. (2007) (41)
- Main results of the Ouabain and Adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin (2011) (41)
- Pharmacogenomics: a new approach to individual therapy of hypertension? (1998) (40)
- Relationship between erythrocyte volume and sodium transport in the Milan hypertensive rat and age-dependent changes. (1987) (40)
- Travel‐related disseminated Penicillium marneffei infection in a renal transplant patient (2012) (40)
- Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine (1999) (39)
- Increased arterial smooth muscle Ca2+ signaling, vasoconstriction, and myogenic reactivity in Milan hypertensive rats. (2012) (39)
- Paired kidney donations to expand the living donor pool: the Western Australian experience (2009) (38)
- Structure-based design and synthesis of novel potent Na+,K+ -ATPase inhibitors derived from a 5alpha,14alpha-androstane scaffold as positive inotropic compounds. (2003) (37)
- Reproducibility of insulin sensitivity measured by the minimal model method (1991) (36)
- Prescribing angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease (Review Article) (2007) (36)
- Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension. (2010) (36)
- High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population (2007) (35)
- Effect of Add1 gene transfer on blood pressure in reciprocal congenic strains of Milan rats. (2004) (35)
- Substrate and inhibitor specificity of the cloned human 11 beta-hydroxysteroid dehydrogenase type 2 isoform. (1996) (35)
- Antihypertensive Therapy With Ca2+: Antagonist Verapamil and/or ACE Inhibitor Enalapril in NIDDM Patients (1991) (35)
- Providing Better-Matched Donors for HLA Mismatched Compatible Pairs Through Kidney Paired Donation (2017) (35)
- Role of the α-adducin genotype on renal disease progression (2002) (33)
- Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension. (1998) (33)
- Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin, Part 1: Experimental Studies (2010) (33)
- A data-driven approach to identify risk profiles and protective drugs in COVID-19 (2020) (32)
- Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers. (2009) (32)
- Comparison of computer tomographic volumetry versus nuclear split renal function to determine residual renal function after living kidney donation (2014) (31)
- High Transplant Rates of Highly Sensitized Recipients With Virtual Crossmatching in Kidney Paired Donation (2012) (31)
- Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy. (2007) (30)
- Glycolipid Analysis of Different Tissues and Cerebrospinal Fluid in Type II Gaucher Disease (2002) (30)
- Pentoxifylline improves haemoglobin and interleukin‐6 levels in chronic kidney disease (2010) (30)
- Four years of experience with the Australian kidney paired donation programme (2015) (29)
- Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss. (2013) (29)
- Modulation of Renal Calcium Handling by 11β-Hydroxysteroid Dehydrogenase Type 2 (2002) (29)
- Endothelin‐1 infusion inhibits plasma insulin responsiveness in normal men (1998) (28)
- Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension. (1999) (28)
- ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies (2022) (28)
- NKCC2 is activated in Milan hypertensive rats contributing to the maintenance of salt-sensitive hypertension (2011) (28)
- Truncation of the N- and C-terminal regions of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme and effects on solubility and bidirectional enzyme activity (1997) (28)
- Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation. (2000) (27)
- A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial. (2015) (27)
- Optimizing Outcomes in Pediatric Renal Transplantation Through the Australian Paired Kidney Exchange Program (2017) (27)
- CYP11B2-CYP11B1 Haplotypes Associated with Decreased 11β-Hydroxylase Activity (2005) (27)
- The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients. (2009) (26)
- Serum phosphate is an important determinant of corrected serum calcium in end‐stage kidney disease (2009) (26)
- Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach. (2007) (26)
- Modulation of Sarcoplasmic Reticulum Function by PST2744 [Istaroxime; (E,Z)-3-((2-Aminoethoxy)imino) Androstane-6,17-dione Hydrochloride)] in a Pressure-Overload Heart Failure Model (2008) (26)
- Cross talk between plasma membrane Na(+)/Ca (2+) exchanger-1 and TRPC/Orai-containing channels: key players in arterial hypertension. (2013) (26)
- Long-term calcineurin inhibition and magnesium balance after renal transplantation (2003) (26)
- Predictors of perioperative blood transfusions in patients with chronic kidney disease undergoing elective knee and hip arthroplasty (2014) (26)
- Transnational validation of the Australian algorithm for virtual crossmatch allocation in kidney paired donation. (2013) (25)
- The 11β-hydroxysteroid dehydrogenase type II enzyme: Biochemical consequences of the congenital R337C mutation (1996) (25)
- Structural analysis of the 11β-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease (2000) (25)
- Sodium transport kinetics in erythrocytes and inside-out vesicles from Milan rats. (1991) (24)
- Personalized Therapy of Hypertension: the Past and the Future (2016) (24)
- Genetics of the mineralocorticoid system in primary hypertension (2002) (24)
- Waiting Time Between Failure of First Graft and Second Kidney Transplant and Graft and Patient Survival (2016) (24)
- Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus. (2008) (24)
- Hypovolemia contributes to the pathogenesis of orthostatic hypotension in patients with diabetes mellitus. (1999) (23)
- Na+/K+/Cl- cotransport in resealed ghosts from erythrocytes of the Milan hypertensive rats. (1992) (22)
- Ouabain antagonists as antihypertensive agents. (2005) (22)
- Juvenile Hypertension, the Role of Genetically Altered Steroid Metabolism (2001) (22)
- Outcomes of kidney paired donation transplants in relation to shipping and cold ischaemia time (2016) (21)
- Citrate anticoagulation using ACD solution A during long‐term haemodialysis (2011) (21)
- Novel analogues of istaroxime, a potent inhibitor of Na+,K+-ATPase: synthesis and structure-activity relationship. (2008) (21)
- A renal abnormality in the Milan hypertensive strain of rats and in humans predisposed to essential hypertension. (1986) (21)
- Mutations in the 11 beta-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth. (1997) (21)
- Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension (2004) (21)
- Role of the alpha-adducin genotype on renal disease progression. (2002) (21)
- The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complications. (2005) (21)
- Decline in native kidney function in liver transplant recipients is not associated with BK virus infection (2008) (21)
- Pharmacokinetic-Pharmacodynamic Modelling of Magnesium Plasma Concentration and Blood Pressure in Preeclamptic Women (2002) (20)
- Modeling the Benefits and Costs of Integrating an Acceptable HLA Mismatch Allocation Model for Highly Sensitized Patients (2014) (20)
- Altered expression of renal aquaporins and α-adducin polymorphisms may contribute to the establishment of salt-sensitive hypertension. (2011) (20)
- Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output. (2011) (20)
- Antihypertensive Compounds That Modulate the Na‐K Pump (2003) (20)
- Imprinted antibody responses against SARS-CoV-2 Omicron sublineages (2022) (19)
- Left ventricular structure and determinants in normotensive offspring of essential hypertensive parents (1992) (19)
- Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis (2017) (19)
- Comparison of time on the deceased donor kidney waitlist versus time on the kidney paired donation registry in the Australian program (2012) (19)
- Recipient ras gene variants and renal allograft function1 (2002) (19)
- Salt-sensitivity of blood pressure and decreased 11&bgr;-hydroxysteroid dehydrogenase type 2 activity after renal transplantation1 (2002) (19)
- 17beta-O-Aminoalkyloximes of 5beta-androstane-3beta,14beta-diol with digitalis-like activity: synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na(+),K(+)-ATPase receptor. (2000) (19)
- Forms of mineralocorticoid hypertension. (2003) (19)
- Low prevalence of nonconservative mutations of serum and glucocorticoid-regulated kinase (SGK1) gene in hypertensive and renal patients. (2004) (19)
- Diagnosing and preventing iron overload (2017) (19)
- Hip pain in renal transplant recipients: symptomatic gluteus minimus and gluteus medius tendon abnormality as an alternative MRI diagnosis to avascular necrosis. (2007) (19)
- A possible primary role for the kidney in essential hypertension. (1989) (19)
- OASIS-HT: design of a pharmacogenomic dose-finding study. (2005) (19)
- CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. (2005) (18)
- Acute cyclosporine-induced nephrotoxicity in renal transplant recipients: the role of the transplanted kidney. (1996) (18)
- Blood Pressure, Metabolic Variables and Adipose Tissue Distribution in Pre‐And Post‐Menopausal Women (1990) (18)
- Modulation of renal calcium handling by 11 beta-hydroxysteroid dehydrogenase type 2. (2002) (17)
- PST 2238: A New Antihypertensive Compound That Modulates Renal Na-K Pump Function Without Diuretic Activity in Milan Hypertensive Rats (2002) (17)
- Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients (2022) (17)
- α- and β-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy (2009) (17)
- Developing essential hypertension: a syndrome involving ANF deficiency? (1991) (17)
- Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models. (2003) (17)
- A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery (2021) (16)
- Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial (2008) (16)
- Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD? (2009) (16)
- Genetic and experimental hypertension in the animal model-similarities and dissimilarities to the development of human hypertension. (1986) (16)
- A novel mutation in the steroidogenic acute regulatory protein gene promoter leading to reduced promoter activity. (2006) (16)
- A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin. (2006) (16)
- The association of body fat location with haemodynamic and metabolic status in men and women aged 21-60 years. (1991) (16)
- Synthesis, cardiotonic activity, and structure-activity relationships of 17β-guanylhydrazone derivatives of 5β-androstane-3β,14β-diol acting on the Na+,K+-ATPase receptor (1997) (16)
- Kidney paired donation: a plea for a Swiss National Programme. (2015) (15)
- Expression at the haemopoietic stem cell level of the genetically determined erythrocyte membrane defects in the Milan hypertensive rat strain (MHS). (1983) (15)
- Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril (2004) (15)
- Increased Na pump activity in the kidney cortex of the Milan hypertensive rat strain (1991) (15)
- The Codon 213 of the 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Is a Hot Spot for Mutations in Apparent Mineralocorticoid Excess1 (1998) (15)
- Alterations in Energy Metabolism of Hypertrophied Rat Cardiomyocytes: Influence of Propionyl‐L-Carnitine (1995) (15)
- Genetic Mapping and Tailored Antihypertensive Therapy (2000) (15)
- Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis (2013) (15)
- PST 2238: A New Antihypertensive Compound that Modulates Na+,K+‐ATPase and Antagonizes the Pressor Effect of OLF (2006) (15)
- Synthesis and Quantitative Structure−Activity Relationships of 17β-(Hydrazonomethyl)-5β-androstane-3β,14β-diol Derivatives That Bind to Na+,K+-ATPase Receptor (1996) (14)
- Novel analogues of Istaroxime, a potent inhibitor of Na(+),K(+)-ATPase: Synthesis, structure-activity relationship and 3D-quantitative structure-activity relationship of derivatives at position 6 on the androstane scaffold. (2010) (14)
- Familial hypertension and hormonal profile, renal haemodynamics and body fluids of young normotensive subjects. (1978) (14)
- Licorice: a sweet alternative to prevent hyperkalemia in dialysis patients? (2009) (14)
- Rostafuroxin Protects from Podocyte Injury and Proteinuria Induced by Adducin Genetic Variants and Ouabain (2014) (14)
- A genetic approach to the pathogenesis of primary hypertension and to its treatment. (1995) (13)
- Cytochemically assayable Na+,K+-ATPase inhibition by Milan hypertensive rat plasma. (1987) (13)
- Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide. (2002) (13)
- Single dose bioavailability and pharmacokinetic study of a innovative formulation of α-lipoic acid (ALA600) in healthy volunteers. (2011) (13)
- Selective modification of renal alpha 2-adrenergic receptors in Milan hypertensive rat strain. (1987) (12)
- Salt-sensitive blood pressure--an intermediate phenotype predisposing to diabetic nephropathy? (2005) (12)
- Association between serum hepcidin‐25 and primary resistance to erythropoiesis‐stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial (2017) (12)
- Ouabain-dependent signaling in caveolae as a novel therapeutic target for hypertension. (2006) (12)
- Plasma concentrations of catecholamines in two strains of spontaneously hypertensive rats at different ages. (1981) (12)
- The Milan hypertensive rat as a model for studying cation transport abnormality in genetic hypertension. (1987) (12)
- SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy (2021) (12)
- Atrial natriuretic factor increases in response to an acute glucose load (1994) (11)
- Volumes and Na Transports in Intact Red Blood Cells, Resealed Ghosts, and Inside‐Out Vesicles of Milan Hypertensive Rats (1986) (11)
- Characteristics of a ouabain-like factor from Milan hypertensive rats. (1993) (11)
- Challenges of kidney paired donation transplants involving multiple donor and recipient surgeons across Australia (2018) (11)
- [Diagnosis and prevention of uric acid stones]. (2004) (11)
- Role of rat alpha adducin in angiogenesis: null effect of the F316Y polymorphism. (2007) (10)
- The codon 213 of the 11beta-hydroxysteroid dehydrogenase type 2 gene is a hot spot for mutations in apparent mineralocorticoid excess. (1998) (10)
- Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production (2004) (10)
- Age‐dependency and dietary influence on the hypothalamic ouabain‐like factor in Milan hypertensive rats (1995) (10)
- Characterization of erythrocyte adducin from the Milan hypertensive strain of rats (1988) (10)
- Role of rat α adducin in angiogenesis: Null effect of the F316Y polymorphism (2007) (10)
- Enhanced blood pressure response to mineralocorticoid stimulation in normotensive members of hypertensive families. (1992) (9)
- Effect of canrenone and hydrochlorothiazide on the development of hypertension in rat models of genetic hypertension (1993) (9)
- Insulin sensitivity in humans: alterations during drug administration and in essential hypertension. (1990) (9)
- Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial (2015) (9)
- Na+,2Cl-,K+ cotransport system as a marker of antihypertensive activity of new torasemide derivatives. (1992) (9)
- Structural analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease. (2000) (9)
- Postsynaptic α1-Blockade with Terazosin Does Not Modify Insulin Sensitivity in Nonobese Normotensive Subjects (1991) (9)
- The Genomics of Cardiovascular Disorders (2000) (9)
- In vitro function of adult pig islets: effect of culture in different media. (1992) (9)
- alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy. (2010) (8)
- Oxoreductase and dehydrogenase activities of the human and rat 11beta-hydroxysteroid dehydrogenase type 2 enzyme. (1997) (8)
- Unaltered insulin sensitivity during calcium channel blockade with amlodipine (2004) (8)
- Effects of antihypertensive drugs on sexual behaviour of male rats. (1983) (8)
- Effect of Medication Reconciliation at Hospital Admission on 30-Day Returns to Hospital (2021) (7)
- Crossing borders to facilitate live donor kidney transplantation: the Czech‐Austrian kidney paired donation program – a retrospective study (2020) (7)
- Renal Abnormalities at the Prehypertensive Stage of Essential Hypertension (1988) (7)
- Expression of the α3/β1 isoform of human Na,K‐ATPase in the methylotrophic yeast Pichia pastoris (2007) (7)
- The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial (2016) (7)
- The genomics of cardiovascular disorders: therapeutic implications. (2000) (7)
- Atrial natriuretic factor after cardiac surgery with cardiopulmonary bypass in children (1991) (6)
- Pastis and hypertension--what is the molecular basis? (2000) (6)
- Aim, design and methods of the ‘reasons for not intensifying antihypertensive treatment’ (RIAT): an international registry in essential hypertension (2006) (6)
- Predicting intradialytic hypotension from experience, statistical models and artificial neural networks. (2005) (6)
- Treatment of the Hypertensive Diabetic: Focus on Calcium Channel Blockade (1989) (6)
- The distinction between Liddle syndrome and apparent mineralocorticoid excess (2003) (6)
- Functional alterations of mesenteric small resistance arteries in Milan hypertensive and normotensive rats (2009) (6)
- PST 2238 a new antihypertensive compound that modulates renal Na-KATPase in genetic hypertension. (1999) (6)
- Increase in plasma extracellular fluid volume ratio caused by bilateral nephrectomy in patients on maintenance hemodialysis. (1978) (6)
- Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan (2020) (6)
- Cation Transport Abnormalities in Human and Rat Essential Hypertension (1984) (6)
- Effect of amiloride analogues on sodium transport in renal brush border membrane vesicles from Milan hypertensive rats. (1992) (6)
- Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure. (2007) (6)
- Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants (2023) (6)
- Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function (2021) (5)
- [Pharmacologic action of diuretics in the kidney]. (2000) (5)
- Kidney Paired Donation and the “Valuable Consideration” Problem: The Experiences of Australia, Canada, and the United States (2017) (5)
- Renal Mechanisms and Calcium in the Pathogenesis of a Type of Genetic Hypertension (1986) (5)
- Serum fetuin-A and recurrent urolithiasis in young adults. (2013) (5)
- Tacrolimus and mycophenolate mofetil in pig small bowel transplantation: different protocols and their outcome. (1997) (5)
- Cell membrane abnormalities and genetic hypertension. (1986) (5)
- The kidney in essential hypertension. (1985) (5)
- 17 beta-(3-furyl)-5 beta-androstane-3 beta, 14 beta, 17 alpha-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action. (1997) (5)
- Diuretics, mode of action in the kidney (2000) (5)
- Diagnostic investigations in inherited endocrine disorders of sodium regulation (2011) (5)
- Correlations between functional changes and different grades of acute rejection in swine small bowel allografts. (2000) (5)
- Genetic aspects of ion transport systems in hypertension. (1990) (4)
- Activity of 11beta-hydroxysteroid dehydrogenase type 2 in normotensive blacks and whites. (2005) (4)
- Pre‐transplant pharmacokinetic profiling and tacrolimus requirements post‐transplant (2010) (4)
- Genetic Hypertension and the Kidney (1984) (4)
- Reduced plasma cyclic GMP but normal renal responses to atrial natriuretic factor in pre-hypertension. (1996) (4)
- ACE2 engagement exposes the fusion peptide to pan-coronavirus neutralizing antibodies (2022) (4)
- Association between sympathetic activity and the atherogenic serum cholesterol fraction (1990) (4)
- Plasma insulin during physiological and pathophysiological changes in atrial natriuretic factor (1992) (4)
- Synthesis and Quantitative Structure-Activity Relationships of 17β -(Hydrazonomethyl)-5β-androstane-3β,14β-diol Derivatives that Bind to Na+,K+-ATPase Receptor. (1996) (4)
- Membrane abnormalities in essential hypertension: physiologic and genetic links. (1986) (4)
- PST 2238: a new antihypertensive compound that modulates the Na-K pump 'in vivo' and 'in vitro'. (2000) (3)
- Sodium-glucose cotransport inhibitors : mechanisms , metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease (2015) (3)
- Nurturing the benefits of pre-emptive kidney transplantation. (2016) (3)
- Acute kidney injury due to decompression illness (2014) (3)
- The Kidney in Essential Hypertension1 (1985) (3)
- Pre‐ and postdonation kidney function in donors of a kidney paired donation with unique criteria for donor glomerular filtration rate – a longitudinal cohort analysis (2019) (3)
- SIK1 localizes with nephrin in glomerular podocytes and its polymorphism predicts kidney injury. (2014) (3)
- Istaroxime improves diabetic diastolic dysfunction through SERCA stimulation (2019) (3)
- A new selective antagonist of the ouabain pressor effect. (1996) (3)
- [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure]. (2000) (3)
- Defective neutralizing antibody response to SARS-CoV-2 in vaccinated dialysis patients (2021) (3)
- [Immunosuppressive therapy of glomerulonephritis--controlled studies]. (1993) (3)
- Mutation in the beta adducin subunit causes tissue-specific damage to myogenic tone (2011) (3)
- Synthesis, Cardiotonic Activity, and Structure—Activity Relationships of 17β-Guanylhydrazone Derivatives of 5β-Androstane-3β,14β-diol Acting on the Na+,K+-ATPase Receptor. (2010) (3)
- , implications for tubular Na reabsorption renal cells by affecting constitutive endocytosis :-Adducin mutations increase Na / K pump activity in (2008) (2)
- Swiss Hypertension Treatment Programme with Verapamil and/or Enalapril in Diabetic Patients (2012) (2)
- Synthesis, cardiotonic activity, and structure-activity relationships of 17 beta-guanylhydrazone derivatives of 5 beta-androstane-3 beta, 14 beta-diol acting on the Na+,K(+)-ATPase receptor. (1997) (2)
- Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape (2022) (2)
- The reproducibility of COVID-19 data analysis: paradoxes, pitfalls, and future challenges (2022) (2)
- Pharmacokinetic study of intraarterial local intestinal infusion of tacrolimus. (2000) (2)
- [Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study]. (1993) (2)
- SIK1 localizes with nephrin in glomerular podocytes and its polymorphism predicts kidney injury. (2017) (2)
- [Drug-induced gingival hyperplasia]. (1998) (2)
- Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. (2004) (2)
- Data and optimisation requirements for Kidney Exchange Programs (2021) (2)
- Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure (2022) (2)
- Lipoproteins during antihypertensive therapy. Study supported by the Swiss National Science Foundation. (1989) (2)
- Atrial natriuretic factor and autonomic nervous system function in man (2004) (2)
- Changes in cell membrane transport and kidney function in relation to 'essential' hypertension. (1982) (2)
- Ouabain and Adducin for Specific Intervention on Sodium in HyperTension ( OASIS-HT ) : design of a pharmacogenomic dose-finding study (2004) (2)
- Severity of human hypertension in relation to the age in which high blood pressure makes its presumptive appearance. (2003) (2)
- Hypertension related adducin polymorphism affects Na-KATPase activity (1997) (2)
- ESP Bulletin Board (2001) (1)
- Long‐term calcineurin inhibition and magnesium balance after renal transplantation (2003) (1)
- VENLAFAXINE TO TREAT SEVERE HYPOTENSION (2007) (1)
- Increased Circulating Na+-K+-Atpase Inhibitor in the Young and Adult Milan Hypertensive Strain Rat (1986) (1)
- Investigating Genetic Variability between the MHS Hypertensive Strain of Rats and its Normotensive Control, MNS (1988) (1)
- Clonal dissection of immunodominance and cross-reactivity of the CD4+ T cell response to SARS-CoV-2 (2021) (1)
- [Antihypertensive therapy in the nineties]. (1992) (1)
- THE PEAK AND SUM MFI OF THE SINGLE ANTIGEN BEADS (SAB) OF DONOR SPECIFIC ANTI-HLA ANTIBODIES (DSA) AT THE TIME OF TRANSPLANTATION IN RENAL TRANSPLANT RECIPIENTS (RTR) ASSOCIATE WITH THE RISK OF C4D+ REJECTION.: 3039 (2010) (1)
- Intestinal transplantation with and without the colon in FK 506 immunosuppressed pigs. (1996) (1)
- [Heteroarylalkanoic acids with potential anti-inflammatory activity]. (1979) (1)
- Assessment of reasons for not intensifying antihypertensive treatment in the Taiwanese population. (2011) (1)
- [New abdominal wall reconstruction technique with a plastic-rehabilitative intent (back pain improvement)]. (2004) (1)
- Membrane Abnormalities in Essential Hypertension: (1986) (1)
- Differences in hemodynamic stability at reperfusion during intestinal transplantation with and without colon in pigs. (1996) (1)
- APPARENT ADDISON's DISEASE FOLLOWING ILEOSTOMY (2005) (1)
- [Cardiovascular effect of the 1,2,4-benzothiadiazine-1,1-dioxide. IV]. (1974) (1)
- Relationship between red blood cell function, kidney function and blood pressure in genetic hypertension. (1985) (1)
- A Primary Kidney Abnormality in Essential Hypertension1 (1987) (1)
- Prorenin cryoactivation as a possible cause of normal renin levels in patients with primary aldosteronism (2005) (1)
- A primary kidney abnormality in essential hypertension. (1987) (1)
- Synthesis and quantitative structure-activity relationship of 17 beta-(hydrazonomethyl)-5 beta-androstane-3 beta,14 beta-diol derivatives that bind to Na+,K(+)-ATPase receptor. (1996) (1)
- Reduced intestinal myoelectrical activity during rejection of small bowel allografts in pigs. (1996) (1)
- In the cardiovascular system active seco-D-steroids, processes for their preparation and pharmaceutical compositions containing them (1997) (1)
- [Rational assessment procedure in hypertension]. (1992) (1)
- UP-REGULATION OF APICAL SODIUM CHLORIDE COTRANSPORTER AND BASOLATERAL CHLORIDE CHANNELS ARE RESPONSIBLE FOR THE MAINTENANCE OF SALT SENSITIVE HYPERTENSION (2008) (1)
- Sodium pump isoform specificity for digitalis-like factor. (1997) (1)
- Effect of perioperative donor bone marrow infusion after small bowel transplantation in swine: preliminary results. (1998) (1)
- Expression of the alpha3/beta1 isoform of human Na,K-ATPase in the methylotrophic yeast Pichia pastoris. (2007) (1)
- 34 The role of membrane skeleton in the alteration of Na‐K cotransport in Milan hypertensive rats (1988) (1)
- Ion Transport Abnormalities in the Development of Hypertension (1991) (1)
- A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero Trial (2014) (1)
- [Flexibility of the surgical model of intestinal transplantation in swine]. (1997) (1)
- P.28 Effect of total parenteral nutrition on muscleand whole body protein turnover in cancer cachexia (1995) (1)
- Antihypertensive therapy in diabetic patients. (1992) (1)
- tissue inhibitor of the metalloproteinases 1(timp-1) and cardiovascular organe damage in patients with abdominal obesity (2013) (0)
- PST 2238 : Modulates A New Antihypertensive Compound that the NaK Pump ` in Vivo ' and ` in Vitro ' (2006) (0)
- [Molecular genetics of hypertension in the human]. (1999) (0)
- Association of Hypertrophic Cardiomyopathy phenotype and genotype in Italian Maine Coon cats (2009) (0)
- RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity (2022) (0)
- Reply to Gremese et al.: Statistical reasoning to evaluate treatment effects when data are collected with lack of design: Covid-19 experience (2022) (0)
- Arterielle Hypertonie und rasch progrediente Niereninsuffizienz [Arterial hypertension and rapidly progressing renal failure]. (1999) (0)
- Early kidney allograft loss—Is there scope for improvement? (2018) (0)
- Comparison of Time on the Cadaveric Kidney Donor Waitlist Versus Time on the Kidney Paired Donation Registry in the Australian Program: 1401 (2012) (0)
- [Which hypertensive patient requires diuretic therapy?]. (2000) (0)
- Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape (2022) (0)
- Correction (2004) (0)
- Genetic Abnormalities of the Na-K-Cl Cotransport in Experimental and Primary Hypertension (2019) (0)
- Aminoglycosidsteroider, a process for their preparation, their use and pharmaceutical compositions containing them. (1987) (0)
- Digitoxigenin and dihydrodigitoxigenin 3-beta derivatives and pharmaceutical compositions thereof for the treatment of hypertension (1993) (0)
- A new selective antagonist of the ouabain pressor effect (1995) (0)
- New dry-d-steroid active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them. (1997) (0)
- TRANSFER OF α-ADDUCIN GENE FROM MILAN HYPENTENSIVE INTO MILAN NORMOTENSIVE RATS RISES BLOOD PRESSURE AND RENAL NaK PUMP ACTIVITY: P2.109 (2000) (0)
- New cardioactive 17-Iminomethylalkenyl-5-beta-14-beta-androstan and 17-iminoalkyl-5-beta, 14-beta-androstane derivatives, to a process for their preparation and pharmaceutical compositions thereof (1994) (0)
- THE CARDIOVASCULAR EFFECTS OF SUB-NANOMOLAR OUABAIN CONCENTRATIONS DEPEND ON THE SIGNAL-TRANSDUCTION ACTIVATION WITHIN CAVEOLAE AND ARE ANTAGONIZED BY PST 2238: 1C.6 (2004) (0)
- Abstract 3479: RFX1 Transcription Factor Differentially Interacts with Adducin Gly460Trp Variants to Regulate Alpha 1 Na,K-ATPase Gene (ATP1A1) Expression (2008) (0)
- The genetics of essential hypertension (1989) (0)
- 19 Two point mutations within the adducin genes are responsible for variation in blood pressure, kidney and erythrocyte size: a new mechanism for genetic hypertension (1993) (0)
- [Is essential hypertension sustained by a primary intrarenal defect?]. (1979) (0)
- [Cardiovascular action of 1,2,4-benzothiadiazine-1,1-dioxide derivatives. VII]. (1978) (0)
- New 17- (3-imino-2-alkylpropylen) -5ß, 14ss-androstane derivatives, which act on the cardiovascular system, to processes for their preparation and pharmaceutical compositions containing them (1994) (0)
- [How relevant is the trough-to peak ratio?]. (2000) (0)
- Cyclopentanperhydrophenanthren-17-beta- (3-furyl) -3-derivatives and pharmaceutical compositions thereof for the treatment of Cardiovascular Diseases (1993) (0)
- [Cardiovascular effect of 1,2,4-benzothiadiazine-1,1-dioxide derivatives. VIII]. (1978) (0)
- [Hypertension is a frequent illness]. (1999) (0)
- STRUCTURE AND FUNCTION OF MESENTERIC SMALL RESISTANCE ARTERIES IN MILAN HYPERTENSIVE AND NORMOTENSIVE RATS: P3.173 (2004) (0)
- Istaroxime stimulates SERCA 2 a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition 1 Running title : Istaroxime stimulation of SERCA 2 a in heart failure (2013) (0)
- [Cardiovascular effect of the 1,2,4-benzothiadiazine-1,1-dioxide derivatives. V]. (1974) (0)
- 11_-Hydroxysteroid ehydrogenase (2007) (0)
- PREVALENCE OF HYPERTROPHIC CARDIOMYOPATHY (HCM) IN FELINE POPULATION EXAMINED BY THE OSSERVATORIO ITALIANO HCM FELINA (2017) (0)
- The history of paired kidney donation in Australia (2012) (0)
- Comparison of the Virtual Crossmatch Versus Actual Crossmatch in the Austrian Kidney Paired Donation Program: 1402 (2012) (0)
- 1,5 disubstituted derivatives 7a-3a-ol-metilperhidroinden, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them. (1995) (0)
- PRE-TRANSPLANT PHARMACOKINETICS AS A PREDICTOR OF DOSE REQUIREMENT POST RENAL TRANSPLANTATION (2007) (0)
- HETEROARYLALKANOIC ACIDS. POSSIBLE ANTIINFLAMMATORY ACTIVITY (1979) (0)
- New 3,9-disubstituted-spiro [5.5] undecane, a process for their preparation and pharmaceutical compositions containing these (1992) (0)
- Cardioactive 17b-(3-furyl) and 17b-(4-pyridazinyl) -5beta, 14beta-androstane derivatives, processes for their preparation and pharmaceutical compositions thereof (1993) (0)
- Azaheterocyclyl androstane derivatives and androstenes as drugs for cardiovascular disorders (2007) (0)
- 5 BETA 14 BETA-androstane FOR USE FOR THE TREATMENT OF DISEASES CAUSED BY ORGAN FIBROSIS (2008) (0)
- [Arterial hypertension and rapidly progressing renal failure]. (1999) (0)
- FOUR HUMAN GENE VARIANTS PREDICT THE ANTIHYPERTENSIVE ACTIVITY OF ROSTAFUROXIN, A SELECTIVE INHIBITOR OF THEIR EFFECTS ON THE NA, K PUMP: PP.21.316 (2010) (0)
- ABNORMAL CALCIUM HOMEOSTASIS IN ARTERIAL MYOCYTES FROM MILAN HYPERTENSIVE STRAIN RATS: PP.29.177 (2010) (0)
- transporters in the early phase of genetic hypertension + Altered expression of renal apical plasma membrane Na (2016) (0)
- DECLINE IN NATIVE KIDENY FUNCTION IN LIVER TRANSPLANT RECIPIENTS IS NOT ASSOCIATED WITH BKV VIRUS INFECTION: 1345 (2008) (0)
- Hydroxyamino and hydrazino-14beta-hydroxyandrostanderivater with activity on the cardiovascular system, to processes for their preparation and pharmaceutical compositions containing them. (1995) (0)
- 3-beta-digitoxigenin derivatives and dihidrodigitoxigenina and pharmaceutical compositions containing them for the treatment of hypertension. (1993) (0)
- Short communications Plasma insulin during physiological and pathophysiological changes in atrial natriuretic factor (1992) (0)
- A Correction to the Research Article Titled: "Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin. Part 1: Experimental Studies" by Mara Ferrandi, Isabella Molinari, Lucia Torielli, Gloria Padoani, Sergio Salardi, Maria Pia Rastaldi, Patrizia Ferrari, Giu (2010) (0)
- Antihypertensive Treatment Guided by Gene Profiling. The First Randomised Clinical Proof of Concept Trial Proving Feasibility in Man, Comparing Rostafuroxin with Losartan (2019) (0)
- [Diagnostic value of ambulatory daily blood pressure profile: comparison with measurements performed by a laboratory technician]. (1992) (0)
- P.41 Effect of cancer cachexia on muscle and total body protein turnover (1995) (0)
- New Seco-D steroids, which act on the cardiovascular system, to processes for their preparation and pharmaceutical compositions containing them (1996) (0)
- Surveillance of feline inherited diseases in Italy (2015) (0)
- [The skeletal development of the pseudopostmature infant]. (1960) (0)
- [Therapy of hypertension in kidney diseases]. (2003) (0)
- Perioperative inappropriate red blood cell transfusions significantly increase total costs in elective surgical patients, representing an important economic burden for hospitals (2022) (0)
- adducin-dependent hypertension - ATPase alterations in ouabain and + -K + and vascular Na Rostafuroxin: an ouabain antagonist that corrects renal (2016) (0)
- Pharmacokinetics and Safety of Deferasirox in Subjects with Chronic Kidney Disease Undergoing Haemodialysis Running title : Deferasirox in chronic kidney disease (2013) (0)
- Arterial hypertension and rapidly progressive renal failure (1999) (0)
- Derivatives of amino homoandrostaner-B and B-heteroandrostaner (2007) (0)
- [Sodium transport and renal hemodynamics in arterial hypertension of genetic origin: primary or secondary changes?]. (1988) (0)
- Cardioactive 17-and 17-Hydroxyiminoalkyl- Hydroxyiminomethylalkenyl steroid derivatives, a process for their preparation and pharmaceutical preparations thereof (1996) (0)
- Thrombotic Thrombocytopenic Purpura after Allogeneic Hematopoietic Stem Cell Transplantation: A Complication Still Frequent and Responsible of Severe Outcome. (2005) (0)
- EVALUATION OF PERIPHERAL BLOOD DENDRITIC CELLS IN PATIENTS WITH COLONRECTAL CARCINOMA (2010) (0)
- Inotropic properties of a novel Na, K-ATPase inhibitor, PST 2107 (1999) (0)
- Abnormalities in insulin sensitivity, vascular resistance and erythrocyte cation transport are independent genetic traits in familial hypertension. (1999) (0)
- Ca2+ handling in a guinea-pig hypertrophy/failure model (2007) (0)
- The challenge of renal cystic disease and its association with hypertension, age and abnormal potassium handling. (2007) (0)
- 91173444 Blood pressure, metabolic variables and adipose tissue distribution in pre- and post-menopausal women (1991) (0)
- AN OBSERVATIONAL, NON-INTERVENTIONAL, MULTICENTRE, MULTINATIONAL REGISTRY OF PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME (aHUS): INITIAL CHARACTERISTICS OF THE AUSTRALIAN COHORT (2014) (0)
- Hypertension, insulin, and alpha 1-blockade. (1993) (0)
- [Heteroarylalkanoic acids with potential anti-inflammatory activity. II]. (1979) (0)
- Circulating Natriuretic Factor in the Pathogenesis of Genetic Hypertension of Renal Origin (1987) (0)
- Reference intervals for transthoracic echocardiography in the American Staffordshire Terrier (2021) (0)
- maintenance of salt-sensitive hypertension the and basolateral chloride channels is responsible for Upregulation of apical sodium-chloride cotransporter (2011) (0)
- Response to Kute: ‘Facilitators to National Kidney Paired Donation Program’ (2013) (0)
- Third-Party Red-Cell Transfusion in the First 30 Days after Renal Transplantation in Patients with Donor Specific Antibodies Is Associated with Antibody-Mediated Rejection: 1467 (2012) (0)
- [Genetic hypertension in the rat is partially dependent of parathyroid glands. Results of a crossed transplantation trial]. (1993) (0)
- Utilization of deceased donor kidneys to initiate living donor chains: practical, ethical and logistical issues. (2019) (0)
- New sulfonylurea torasemide derivatives as potential antihypertensive drugs (1990) (0)
- Full Reviews Sodium-glucose cotransport inhibitors: mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease (2015) (0)
- The Australian paired Kidney exchange (AKX) program - the first three years (2013) (0)
- Effect of L-carnitine (LC) on oxidative metabolism in isolated cardiac myocytes from normal and hypertrophic rat heart (1992) (0)
- [Cardiovascular action of 1,2,4-benzothiadiazine-1,1-dioxide derivatives. VI]. (1978) (0)
- Luminex Antibody Threshold to Match Donor-Recipient Pairs Using Virtual Crossmatch in Kidney Paired Donation: 726 (2012) (0)
- 3beta-Digitoxigenin- and 3beta-dihydrodigitoxigenin derivatives (1992) (0)
- CARDIOVASCULAR EFFECTS OF CHRONIC LOW-DOSE OUABAIN ADMINISTRATION IN RATS: P2.106 (2004) (0)
- 163. Characteristics of sodium???potassium-chloride cotransport in resealed ghosts in the Milan rat strain (1991) (0)
- Catecholaminergic Receptors in Kidney of Milano Hypertensive Rats (1986) (0)
- New 17- (3-imino-2-alkyl-propenyl) -5beta-14beta-androstane derivatives for the treatment of cardiovascular diseases, a process for their preparation and pharmaceutical compositions thereof (1995) (0)
- EFFECT OF THE HUMAN MUTATED ALPHA-ADDUCIN ON THE NA/K PUMP: P2.223 (2004) (0)
- Digitoxigenin and dihydrodigitoxigenin 3 beta derivatives and to pharmaceutical compositions containing them for the treatment of hypertension (1993) (0)
- Molecular genetics of human hypertension (1999) (0)
- Nor-cholansyrederivater, process for their preparation, their use and pharmaceutical compositions containing them. (1987) (0)
- Differential impact of transfusion guidelines on blood transfusion practices within a health network. (2023) (0)
- CARDIOVASCULAR HEALTH ACTIVITY OF 11 b-HYDROXYSTEROID DEHYDROGENASE TYPE 2 IN NORMOTENSIVE BLACKS AND WHITES (0)
- SP790 LOW DOSE VALGANCICLOVIR PROPHYLAXIS AMONG RENAL TRANSPLANTS: COST BENEFIT ANALYSIS (2017) (0)
- Author's Response: In Vivo Measurements of Renal 11ss-Hydroxysteroid Dehydrogenase Type 2 Activity. (2000) (0)
- Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System (1993) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paolo Ferrari?
Paolo Ferrari is affiliated with the following schools:
